PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350247
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350247
Global ESR tubes market is estimated to be valued at US$ 122.7 million in 2023, and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 122.7 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 5.60% | 2030 Value Projection: | US$ 179.6 Mn |
ESR tubes are used to conduct erythrocyte sedimentation rate (ESR) blood test thathelps to measure how quickly erythrocytes (red blood cells) settle at the bottom of a test tube that contains a blood sample. The ESR tubes are made up of plastic and glass materials with anticoagulant additives such as sodium citrate. In normal blood sample, erythrocytes settle slowly at the bottom of a test tube. The faster rate of erythrocyte sedimentation indicates inflammation in the body. The inflammation in the body is caused by the immune responses to infection or injury. The ESR test is used to determine symptoms of an inflammatory disorder such as weight loss, fever, anemia, and headache. The ESR tubes are used with ESR analyzers for clinical and diagnostic purposes. The ESR Analyzer also known as Erythrocyte sedimentation rate (ESR) analyzer is a common hematological tester that is utilized for measuring the rate, at which the red blood cells or erythrocytes settle in a period of one hour. ESR analyzer detects the non-specific inflammation caused by active infection, cancer, heart disease, kidney disease, blood disease, diabetes, and collagen vascular disease. Increasing prevalence of cancer, arthritis, and kidney diseases worldwide, and rising adoption of semi-automatic and automatic ESR analyzers as well as recent product launches from leading market players are factors that are accelerating the global products demand.
Increasing demand for erythrocyte sedimentation rate (ESR), as biomarker used as a general condition indicator is expected to drive growth of the global ESR tubes market. ESR measurement is useful in the diagnosis of rheumatoid arthritis, temporal arthritis, polymyalgia rheumatic, multiple myeloma, certain cancers and several autoimmune diseases. Clinical studies have also suggested possible relevance of ESR levels in different other conditions. For instance, in March 2022, Shenzhen Mindray Bio-Medical Electronics Co., a China-based multinational medical instrumentation manufacturer, launched the new BC-700 Series, a new hematology analyzer series that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests.